Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis
Open Access
- 26 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Nephrology
- Vol. 12 (1), 3
- https://doi.org/10.1186/1471-2369-12-3
Abstract
Defined as estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, chronic kidney disease (CKD) is strongly and independently associated with cardiovascular and overall mortality. We hypothesized that reduced kidney function would be characterized by abnormalities of hemostasis. We tested cross-sectional associations between (eGFR) and multiple hemostatic markers among 6751 participants representing a broad spectrum of kidney function in the Multi-Ethnic Study of Atherosclerosis (MESA). Kidney function was measured using cystatin C (eGFRcys) or creatinine, using CKD Epidemiology Collaboration (eGFRcr). Hemostatic markers included soluble thrombomodulin (sTM), soluble tissue factor (sTF), D-Dimer, von Willebrand factor (vWF), factor VIII, plasmin-antiplasmin complex (PAP), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), and fibrinogen. Associations were tested using multivariable linear regression with adjustment for demographics and comorbidities. In comparison to persons with eGFRcys >90 ml/min/1.73 m2, subjects with eGFRcys < 60 ml/min/1.73 m2 had adjusted levels of sTM, sTF, D-Dimer, PAP, Factor VIII, TFPI, vWF and fibrinogen that were respectively 86%, 68%, 44%, 22%, 17%, 15%, 12% and 6% higher. Subjects with eGFRcys 60-90 ml/min/1.73 m2 had adjusted levels that were respectively 16%, 14%, 12%, 6%, 6%, 6%, 11% and 4% higher (p < 0.05 for all). Percent differences were not significantly different when groups were categorized by eGFRcr. Throughout a broad spectrum of kidney function, lower eGFR was associated with higher levels of hemostatic markers. Dysregulation of hemostasis may be a mechanism by which reduced kidney function promotes higher cardiovascular risk.Keywords
This publication has 44 references indexed in Scilit:
- Chronic kidney disease and venous thromboembolism: a prospective studyNephrology Dialysis Transplantation, 2010
- Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health StudyNephrology Dialysis Transplantation, 2009
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanismsCurrent Opinion in Pulmonary Medicine, 2009
- Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Kidney Diseases, 2009
- Associations of factor VIIIc, D‐dimer, and plasmin–antiplasmin with incident cardiovascular disease and all‐cause mortalityAmerican Journal of Hematology, 2009
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease PatientClinical Journal of the American Society of Nephrology, 2008
- Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul StudyNephrology Dialysis Transplantation, 2007
- Soluble thrombomodulin and coronary heart diseaseCurrent Opinion in Lipidology, 2003
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000